NASDAQILMN

JHVEPhoto/iStock Editorial via Getty Images GRAIL (GRAL) will begin trading on the Nasdaq as a publicly-listed independent company on Tuesday, after Illumina (NASDAQ:ILMN) completed the spinoff of the cancer test developer following regulatory pressure. It will be listed and begin regular trading on the Nasdaq under the symbol “GRAL” asContinue Reading